• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在甲状腺激素受体β或α基因无突变的甲状腺激素抵抗家族中,寻找核共抑制因子、共激活因子及一种辅调节因子的异常情况。

Search for abnormalities of nuclear corepressors, coactivators, and a coregulator in families with resistance to thyroid hormone without mutations in thyroid hormone receptor beta or alpha genes.

作者信息

Reutrakul S, Sadow P M, Pannain S, Pohlenz J, Carvalho G A, Macchia P E, Weiss R E, Refetoff S

机构信息

Department of Medicine, University of Chicago, Illinois 60637-1470, USA.

出版信息

J Clin Endocrinol Metab. 2000 Oct;85(10):3609-17. doi: 10.1210/jcem.85.10.6873.

DOI:10.1210/jcem.85.10.6873
PMID:11061510
Abstract

The syndrome of resistance to thyroid hormone (RTH) is characterized by decreased tissue responsiveness to thyroid hormones. Inheritance is usually autosomal dominant due to mutations in the ligand-binding domain or adjacent hinge region of the thyroid hormone receptor beta (TRbeta) gene. Six of 65 families with the RTH phenotype studied in our laboratory had normal TRbeta1 and TRbeta2 gene sequences. Their clinical characteristics were not different from those of subjects with TRbeta gene mutations. Four of the 6 families were amenable to linkage analysis, and TRalpha involvement was excluded. Candidate genes were then evaluated for their possible involvement in the RTH phenotype in these 4 families: 2 coactivators [NCoA-1 (SRC-1) and NCoA-3 (AIB-1)], 2 corepressors (NCoR and SMRT), and a coregulator (RXRgamma). DNA was obtained from 8 affected subjects and 41 of 45 living first degree relatives. In 2 of the 4 families, the mode of inheritance could be determined by pedigree analysis and was found to be autosomal dominant. Linkage analyses were performed using polymorphic markers near or within the 5 candidate genes. When analyses were not informative or linkage could not be excluded, direct sequencing of the genes in question was performed. Involvement of NCoA-1 was excluded in all four families assuming autosomal dominant inheritance. Roles for NCoR, SMRT, and NCoA-3 were excluded in three and a role for RXRgamma was excluded in two of the four families. However, if the two families without proven dominant mode of inheritance were compound heterozygous, only the involvement of NCoA-1 could be excluded in both. Roles for NCoR, SMRT, and RXRgamma were excluded in one of these two families. Thus, NCoA-1 and RXRgamma genes were not found to be the cause of RTH in subjects without TR gene mutations even though the absence of NCoA-1 and RXRgamma is the cause of RTH in mice. Involvement of other candidate genes in the mediation of thyroid hormone action as well as intracellular hormone transport needs to be explored in these families with non-TRbeta, TRalpha RTH.

摘要

甲状腺激素抵抗综合征(RTH)的特征是组织对甲状腺激素的反应性降低。由于甲状腺激素受体β(TRβ)基因的配体结合域或相邻铰链区发生突变,其遗传方式通常为常染色体显性遗传。在我们实验室研究的65个具有RTH表型的家族中,有6个家族的TRβ1和TRβ2基因序列正常。他们的临床特征与具有TRβ基因突变的受试者无异。这6个家族中有4个适合进行连锁分析,并且排除了TRα的参与。然后对这4个家族中可能与RTH表型有关的候选基因进行评估:2种共激活因子[NCoA-1(SRC-1)和NCoA-3(AIB-1)]、2种共抑制因子(NCoR和SMRT)以及1种辅调节因子(RXRγ)。从8名受影响的受试者和45名在世的一级亲属中的41人获取了DNA。在这4个家族中的2个家族中,遗传方式可通过系谱分析确定,发现为常染色体显性遗传。使用5个候选基因附近或内部的多态性标记进行连锁分析。当分析无信息价值或无法排除连锁关系时,对相关基因进行直接测序。假设为常染色体显性遗传,在所有4个家族中均排除了NCoA-1的参与。在4个家族中的3个家族中排除了NCoR、SMRT和NCoA-3的作用,在4个家族中的2个家族中排除了RXRγ的作用。然而,如果这两个未证实为显性遗传方式的家族是复合杂合子,那么在这两个家族中都只能排除NCoA-1的参与。在这两个家族中的一个家族中排除了NCoR、SMRT和RXRγ的作用。因此,即使在小鼠中NCoA-1和RXRγ的缺失是RTH的病因,但在没有TR基因突变的受试者中,未发现NCoA-1和RXRγ基因是RTH的病因。在这些非TRβ、TRα RTH的家族中,需要探索其他候选基因在甲状腺激素作用介导以及细胞内激素转运中的作用。

相似文献

1
Search for abnormalities of nuclear corepressors, coactivators, and a coregulator in families with resistance to thyroid hormone without mutations in thyroid hormone receptor beta or alpha genes.在甲状腺激素受体β或α基因无突变的甲状腺激素抵抗家族中,寻找核共抑制因子、共激活因子及一种辅调节因子的异常情况。
J Clin Endocrinol Metab. 2000 Oct;85(10):3609-17. doi: 10.1210/jcem.85.10.6873.
2
Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene.五个新的甲状腺激素抵抗家族,并非由甲状腺激素受体β基因突变所致。
J Clin Endocrinol Metab. 1999 Nov;84(11):3919-28. doi: 10.1210/jcem.84.11.6080.
3
Dominant inheritance of resistance to thyroid hormone not linked to defects in the thyroid hormone receptor alpha or beta genes may be due to a defective cofactor.对甲状腺激素抵抗的显性遗传与甲状腺激素受体α或β基因缺陷无关,可能是由于辅助因子缺陷所致。
J Clin Endocrinol Metab. 1996 Dec;81(12):4196-203. doi: 10.1210/jcem.81.12.8954015.
4
Resistance to thyroid hormone caused by two mutant thyroid hormone receptors beta, R243Q and R243W, with marked impairment of function that cannot be explained by altered in vitro 3,5,3'-triiodothyroinine binding affinity.由两种突变型甲状腺激素受体β(R243Q和R243W)引起的甲状腺激素抵抗,其功能明显受损,这无法通过体外3,5,3'-三碘甲状腺原氨酸结合亲和力的改变来解释。
J Clin Endocrinol Metab. 1997 May;82(5):1608-14. doi: 10.1210/jcem.82.5.3945.
5
Defective release of corepressor by hinge mutants of the thyroid hormone receptor found in patients with resistance to thyroid hormone.在甲状腺激素抵抗患者中发现的甲状腺激素受体铰链区突变体导致共抑制因子释放缺陷。
J Biol Chem. 1998 Nov 13;273(46):30175-82. doi: 10.1074/jbc.273.46.30175.
6
A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor corepressors and coactivators.甲状腺激素受体中的一种新型自然突变定义了一个可交换核受体共抑制因子和共激活因子的双功能结构域。
Mol Endocrinol. 1998 Dec;12(12):1888-902. doi: 10.1210/mend.12.12.0201.
7
Mosaicism of a thyroid hormone receptor-beta gene mutation in resistance to thyroid hormone.甲状腺激素抵抗中甲状腺激素受体-β基因突变的嵌合体现象。
J Clin Endocrinol Metab. 2006 Sep;91(9):3471-7. doi: 10.1210/jc.2006-0727. Epub 2006 Jun 27.
8
A novel thyroid hormone receptor-beta mutation that fails to bind nuclear receptor corepressor in a patient as an apparent cause of severe, predominantly pituitary resistance to thyroid hormone.一名患者中出现一种新型甲状腺激素受体β突变,该突变无法结合核受体共抑制因子,这显然是导致严重的、主要为垂体性甲状腺激素抵抗的原因。
J Clin Endocrinol Metab. 2006 May;91(5):1887-95. doi: 10.1210/jc.2005-2428. Epub 2006 Feb 7.
9
A de novo mutation in an already mutant nucleotide of the thyroid hormone receptor beta gene perpetuates resistance to thyroid hormone.甲状腺激素受体β基因中一个已发生突变的核苷酸出现的新发突变使对甲状腺激素的抵抗持续存在。
J Clin Endocrinol Metab. 2005 Mar;90(3):1760-7. doi: 10.1210/jc.2004-1488. Epub 2004 Dec 14.
10
Search for genetic variants in the retinoid X receptor-gamma-gene by polymerase chain reaction-single-strand conformation polymorphism in patients with resistance to thyroid hormone without mutations in thyroid hormone receptor beta gene.在甲状腺激素受体β基因无突变的甲状腺激素抵抗患者中,通过聚合酶链反应-单链构象多态性方法寻找视黄酸X受体γ基因中的遗传变异。
Thyroid. 2004 May;14(5):355-8. doi: 10.1089/105072504774193177.

引用本文的文献

1
A Case of Thyroid Hormone Resistance Syndrome with a Novel Mutation (c.947G>a) in the Gene: Experience in Diagnosis and Treatment.一例甲状腺激素抵抗综合征伴基因新突变(c.947G>a):诊断与治疗经验
Int Med Case Rep J. 2024 Nov 13;17:959-964. doi: 10.2147/IMCRJ.S486498. eCollection 2024.
2
Resistance to Thyroid Hormone Beta: A Focused Review.抗甲状腺激素β受体:专题述评。
Front Endocrinol (Lausanne). 2021 Mar 31;12:656551. doi: 10.3389/fendo.2021.656551. eCollection 2021.
3
Hypercholesterolemia in Two Siblings with Resistance to Thyroid Hormones Due to Disease-Causing Variant in Thyroid Hormone Receptor () Gene.
两名患有甲状腺激素抵抗症的兄妹存在高胆固醇血症,其致病原因是甲状腺激素受体()基因突变。
Medicina (Kaunas). 2020 Dec 15;56(12):699. doi: 10.3390/medicina56120699.
4
Familial Dysalbuminemic Hyperthyroxinemia: An Underdiagnosed Entity.家族性异常白蛋白血症性高甲状腺素血症:一种诊断不足的疾病。
J Clin Med. 2020 Jul 3;9(7):2105. doi: 10.3390/jcm9072105.
5
Genomic and Non-Genomic Mechanisms of Action of Thyroid Hormones and Their Catabolite 3,5-Diiodo-L-Thyronine in Mammals.甲状腺激素及其代谢产物 3,5-二碘-L-甲状腺原氨酸在哺乳动物中的基因组和非基因组作用机制。
Int J Mol Sci. 2020 Jun 10;21(11):4140. doi: 10.3390/ijms21114140.
6
Thyroid Hormone Hyposensitivity: From Genotype to Phenotype and Back.甲状腺激素低敏性:从基因型到表型再回归
Front Endocrinol (Lausanne). 2020 Jan 24;10:912. doi: 10.3389/fendo.2019.00912. eCollection 2019.
7
Identification of a novel mutation in the thyroid hormone receptor β gene that causes thyroid hormone resistance syndrome: A case report.鉴定导致甲状腺激素抵抗综合征的甲状腺激素受体 β 基因突变:一例报告。
Mol Med Rep. 2019 Nov;20(5):4683-4687. doi: 10.3892/mmr.2019.10703. Epub 2019 Sep 24.
8
A clinician's guide to understanding resistance to thyroid hormone due to receptor mutations in the TRα and TRβ isoforms.临床医生指南:理解因TRα和TRβ亚型受体突变导致的甲状腺激素抵抗
Clin Diabetes Endocrinol. 2017 Sep 15;3:8. doi: 10.1186/s40842-017-0046-z. eCollection 2017.
9
Defects of Thyroid Hormone Synthesis and Action.甲状腺激素合成和作用缺陷。
Endocrinol Metab Clin North Am. 2017 Jun;46(2):375-388. doi: 10.1016/j.ecl.2017.01.005. Epub 2017 Mar 6.
10
Syndrome of Reduced Sensitivity to Thyroid Hormones: Two Case Reports and a Literature Review.甲状腺激素敏感性降低综合征:两例报告及文献综述
Case Rep Endocrinol. 2016;2016:7546453. doi: 10.1155/2016/7546453. Epub 2016 Sep 28.